Teligent ROE 2012-2021 | TLGT

Current and historical return on equity (ROE) values for Teligent (TLGT) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Teligent ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2021-06-30 $-0.09B $-0.06B 162.83%
2021-03-31 $-0.09B $-0.06B 169.09%
2020-12-31 $-0.12B $-0.06B 221.82%
2020-09-30 $-0.05B $-0.03B 163.48%
2020-06-30 $-0.05B $-0.02B 282.67%
2020-03-31 $-0.04B $-0.01B 573.33%
2019-12-31 $-0.03B $0.00B -833.33%
2019-09-30 $-0.03B $0.01B -388.57%
2019-06-30 $-0.03B $0.02B -174.65%
2019-03-31 $-0.04B $0.03B -155.34%
2018-12-31 $-0.04B $0.03B -108.27%
2018-09-30 $-0.03B $0.04B -70.00%
2018-06-30 $-0.03B $0.04B -75.43%
2018-03-31 $-0.02B $0.05B -43.30%
2017-12-31 $-0.02B $0.05B -28.30%
2017-09-30 $-0.01B $0.06B -25.00%
2017-06-30 $-0.01B $0.06B -13.62%
2017-03-31 $-0.01B $0.06B -16.60%
2016-12-31 $-0.01B $0.06B -19.20%
2016-09-30 $-0.01B $0.07B -20.00%
2016-06-30 $-0.01B $0.07B -19.19%
2016-03-31 $0.00B $0.07B -1.42%
2015-12-31 $0.01B $0.07B 10.73%
2015-09-30 $0.02B $0.06B 32.62%
2015-06-30 $0.02B $0.05B 45.60%
2015-03-31 $0.01B $0.03B 41.27%
2014-12-31 $0.01B $0.02B 27.27%
2014-09-30 $0.00B $0.01B -7.14%
2014-06-30 $0.00B $0.01B -13.79%
2014-03-31 $0.00B $0.01B -14.81%
2013-12-31 $0.00B $0.01B -16.00%
2013-09-30 $0.00B $0.01B -16.67%
2013-06-30 $0.00B $0.01B -34.78%
2013-03-31 $0.00B $0.01B -50.00%
2012-12-31 $0.00B $0.01B -64.00%
2012-09-30 $0.00B $0.01B -59.26%
2012-06-30 $0.00B $0.01B -40.00%
2012-03-31 $0.00B $0.01B -37.50%
2011-12-31 $0.00B $0.01B -35.29%
2011-09-30 $0.00B $0.01B -33.33%
2011-06-30 $-0.01B $0.01B -62.50%
2011-03-31 $-0.01B $0.01B -71.43%
2010-12-31 $-0.01B $0.01B -80.00%
2010-09-30 $-0.01B $0.01B -100.00%
2010-06-30 $0.00B $0.01B -72.73%
2010-03-31 $-0.01B $0.01B -116.67%
2009-12-31 $-0.01B $0.01B -145.45%
2009-09-30 $-0.01B $0.01B -160.00%
2009-06-30 $-0.01B $0.00B -188.24%
2009-03-31 $-0.01B $0.00B -142.86%
2008-12-31 $0.00B $0.00B -85.71%
2008-09-30 $0.00B $0.00B -53.33%
2008-06-30 $0.00B $0.00B -26.67%
2008-03-31 $0.00B $0.00B 0.00%
2007-12-31 $0.00B $0.00B 0.00%
2007-09-30 $0.00B $0.00B 0.00%
2007-06-30 $0.00B $0.00B -40.00%
2007-03-31 $0.00B $0.00B -40.00%
2006-12-31 $0.00B $0.00B -40.00%
2006-09-30 $0.00B $0.00B -36.36%
2006-06-30 $0.00B $0.00B -33.33%
2006-03-31 $0.00B $0.00B -30.77%
2005-12-31 $0.00B $0.00B -28.57%
2005-09-30 $0.00B $0.00B -26.67%
2005-06-30 $0.00B $0.00B 0.00%
2005-03-31 $0.00B $0.00B -25.00%
2004-12-31 $0.00B $0.00B -25.00%
2004-09-30 $0.00B $0.00B -25.00%
2004-06-30 $0.00B $0.00B -25.00%
2004-03-31 $0.00B $0.00B 0.00%
2003-12-31 $0.00B $0.00B 0.00%
2003-09-30 $0.00B $0.01B 22.22%
2003-06-30 $0.00B $0.01B 0.00%
2003-03-31 $0.01B $0.01B 189.47%
2002-12-31 $0.01B $0.00B 400.00%
2002-09-30 $0.01B -0 -3228180212899171840.00%
2002-06-30 $0.01B $0.00B -400.00%
2002-03-31 $0.00B $0.00B 53.33%
2001-12-31 $0.00B $0.00B 57.14%
2001-09-30 $0.00B $0.00B 30.77%
2001-06-30 $-0.01B $0.00B 366.67%
2001-03-31 $-0.01B -0 4611686018427387392.00%
2000-12-31 $-0.01B $0.00B -488.89%
2000-09-30 $-0.01B $0.01B -266.67%
2000-06-30 $0.00B $0.01B -15.38%
2000-03-31 $0.00B $0.01B -34.78%
1999-12-31 $0.00B $0.01B -16.67%
1999-09-30 $0.00B $0.01B -16.67%
1999-06-30 $0.00B $0.01B -33.33%
1999-03-31 $0.00B $0.01B -48.00%
1998-12-31 $0.00B $0.01B -44.44%
1998-09-30 $-0.01B $0.01B -68.97%
1998-06-30 $0.00B $0.01B -47.06%
1998-03-31 $0.00B $0.01B -31.58%
1997-12-31 $0.00B $0.01B -30.00%
1997-09-30 $0.00B $0.01B 0.00%
1997-06-30 $0.00B $0.01B 0.00%
1997-03-31 $0.00B $0.01B 0.00%
1996-12-31 $0.00B $0.01B 0.00%
1996-09-30 $0.00B $0.01B -10.53%
1996-06-30 $0.00B $0.01B -18.60%
1996-03-31 $0.00B $0.01B -24.49%
1995-12-31 $0.00B $0.01B -14.04%
1995-09-30 $0.00B $0.02B -12.90%
1995-06-30 $0.00B $0.02B 0.00%
1995-03-31 $0.00B $0.02B 13.79%
1994-12-31 $0.00B $0.01B 7.41%
1994-09-30 $0.00B $0.01B -15.38%
1994-06-30 $0.00B $0.01B -22.22%
1994-03-31 $0.00B $0.01B -28.57%
1993-12-31 $0.00B $0.02B -27.59%
1993-09-30 $0.00B $0.02B 0.00%
1993-06-30 $0.00B $0.02B 0.00%
1993-03-31 $0.00B $0.02B 0.00%
1992-12-31 $0.00B $0.02B 0.00%
1992-09-30 $0.00B $0.02B 0.00%
1992-06-30 $0.00B $0.01B 0.00%
1992-03-31 $0.00B $0.01B 0.00%
1991-12-31 $0.00B $0.01B 0.00%
1991-09-30 $0.00B $0.01B 0.00%
1991-06-30 $0.00B $0.01B 0.00%
1991-03-31 $0.00B $0.01B 0.00%
1990-12-31 $0.00B $0.01B 0.00%
1990-09-30 $0.00B $0.01B 0.00%
1990-06-30 $0.00B $0.01B 0.00%
1990-03-31 $0.00B $0.01B 0.00%
1989-12-31 $0.00B $0.01B 0.00%
1989-09-30 $0.00B $0.01B 0.00%
1989-06-30 $0.00B $0.01B 0.00%
1989-03-31 $0.00B $0.01B 0.00%
1988-12-31 $0.00B $0.01B 0.00%
1988-09-30 $0.00B $0.01B 0.00%
1988-06-30 $0.00B $0.01B 0.00%
1988-03-31 $0.00B $0.01B 0.00%
1987-12-31 $0.00B $0.01B 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.000B $0.000B
Teligent, Inc. is a specialty generic pharmaceutical company, develops, manufactures and markets topical formulations primarily in the United States. It sells generic pharmaceutical products in topical, injectable, complex and ophthalmic dosage forms. Teligent Inc., formerly known as IGI Laboratories, Inc., is based in Buena, New Jersey.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $35.437B 10.97
BridgeBio Pharma (BBIO) United States $14.460B 0.00
Dr Reddy's Laboratories (RDY) India $11.109B 17.29
Aspen Pharmacare (APNHY) South Africa $3.708B 0.00
Supernus Pharmaceuticals (SUPN) United States $2.918B 22.33
Bausch Health Cos (BHC) Canada $2.086B 1.50
Taysha Gene Therapies (TSHA) United States $1.290B 0.00
Amphastar Pharmaceuticals (AMPH) United States $0.924B 7.28
Personalis (PSNL) United States $0.630B 0.00
Assembly Biosciences (ASMB) United States $0.451B 0.00
Sol-Gel Technologies (SLGL) Israel $0.210B 0.00
Metagenomi Therapeutics (MGX) United States $0.052B 0.00
Evoke Pharma (EVOK) United States $0.019B 0.00